Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Oncology Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1421616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of myelomonocytic cells during differentiation into macrophages.

  1992cited by this paper
• Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases.

  1991cited by this paper
• Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas.

  1991cited by this paper
• A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Prognostic significance of proliferative activity of diffuse large cell lymphomas.

  1991cited by this paper
• Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.

  1991cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

  1990cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.

  1990cited by this paper
• Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice.

  1990cited by this paper
• Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

  1990cited by this paper
• Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha.

  1990cited by this paper
• Identification of an inhibitor of neovascularization from cartilage.

  1990cited by this paper
• Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

  1989cited by this paper
• Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.

  1989cited by this paper
• Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA.

  1989cited by this paper
• Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms.

  1989cited by this paper
• Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately?

  1989cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• Molecular aspects of the metastatic cascade.

  1989cited by this paper
• Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells.

  1989cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

  1988cited by this paper
• Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.

  1988cited by this paper
• The collagenase gene family in humans consists of at least four members.

  1988cited by this paper
• In vivo effect of human erythroid-potentiating activity on hematopoiesis in mice.

  1988cited by this paper
• Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.

  1988cited by this paper
• Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.

  1988cited by this paper
• Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.

  1987cited by this paper
• Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.

  1986cited by this paper
• Comparison of human stromelysin and collagenase by cloning and sequence analysis.

  1986cited by this paper
• Proteolytic Enzymes in Cancer Invasion and Metastasis

  1986cited by this paper
• A study of mitochondrial and nuclear transcription with cloned cDNA probes. Changes in the relative abundance of mitochondrial transcripts after stimulation of quiescent mouse fibroblasts.

  1985cited by this paper
• Lymphoid tumors displaying rearrangements of both immunoglobulin and T cell receptor genes

  1985cited by this paper
• Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic" neoplasms.

  1985cited by this paper
• Most null large cell lymphomas are B lineage neoplasms.

  1985cited by this paper
• A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

  1981cited by this paper
• An improper use of statistical significance testing in studying covariables.

  1978cited by this paper

• Treatment of Malignant Gliomas by Therapies Against Matrix Metalloproteinases

  2020cites this paper
• Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression.

  2016cites this paper
• Non-Hodgkin's Lymphomas and Tissue Inhibitor of Metalloproteinase (TIMP-1) Expression in Malignant Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9)

  2013cites this paper
• Étude de l'activité anti-cancéreuse du PCK3145, un peptide dérivé de PSP-94, sur les cancers hématologiques

  2009cites this paper
• Gelatinases, their tissue inhibitors and p53 in lymphomas

  2009cites this paper
• ROLE OF GELATINASES (MMP-2 AND MMP-9), TIMP-1, VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), AND MICROVESSEL DENSITY ON THE CLINICOPATHOLOGICAL BEHAVIOR OF CHILDHOOD NON-HODGKIN LYMPHOMA

  2008cites this paper
• The cloning and expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase 2 in normal canine lymph nodes and in canine lymphoma.

  2008cites this paper
• Endogenous thrombospondin-1 and proteases in the regulation of lymphocyte adhesion and motility

  2008cites this paper
• Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.

  2007cites this paper
• Regulation of NF-κB Function

  2007cites this paper
• Plasma MMP‐2‐TIMP‐2 complex levels measured during follow‐up predict a risk of relapse in patients with malignant lymphoma

  2007cites this paper
• Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.

  2006cites this paper
• TIMP-1: Zelluläre Funktion und Beeinflussung der Genexpression von Matrix-Metalloproteinasen in humanen Hepatomzellen

  2006cites this paper
• High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma

  2004cites this paper
• Adenovirus‐mediated overexpression of tissue inhibitor of metalloproteinases‐1 in the liver: efficient protection against T‐cell lymphoma and colon carcinoma metastasis

  2004cites this paper
• Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

  2004cites this paper
• Infiltrative capacity of T leukemia cell lines: A distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1)

  2004cites this paper
• Clinicopathological correlations of TIMP‐1 and TIMP‐2 in Hodgkin's lymphoma

  2004cites this paper
• Increase of Anti-Metastatic Efficacy by Selectivity- But Not Affinity-Optimization of Synthetic Serine Protease Inhibitors

  2003cites this paper
• Gelatinases (MMP‐2 and MMP‐9), TIMP‐1 expression and the extent of neovascularization in aggressive non‐Hodgkin's lymphomas

  2003cites this paper
• Matrix-metalloproteinases in Hodgkin lymphoma.

  2003cites this paper
• Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression.

  2002cites this paper
• Proteases and Their Inhibitors in Cancer Metastasis

  2002cites this paper
• Tissue Inhibitors of Metalloproteinases in Cancer

  2002cites this paper
• Proteases and Their Inhibitors in Gliomas

  2002cites this paper
• Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity.

  2001cites this paper
• Matrix Metalloproteinases and Their Tissue Inhibitors - Expression, Role and Regulation in Human Malignant Non-Hodgkin's Lymphomas

  2000cites this paper
• Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status

  2000cites this paper
• Resistance of ICAM-1 – deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells

  1999cites this paper
• Paradoxical preservation of a lipopolysaccharide response in C3H/HeJ macrophages: induction of matrix metalloproteinase-9.

  1999cites this paper
• Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.

  1999cites this paper
• Matrix Metalloproteinases in the Hematopoietic Microenvironment.

  1999cites this paper
• Expression of matrix metalloproteinases (MMP‐2 and ‐9) and tissue inhibitors of metalloproteinases (TIMP‐1 and ‐2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells

  1999cites this paper
• Metalloproteinase-9Macrophages: Induction of Matrix Lipopolysaccharide Response in C3H/HeJ Paradoxical Preservation of a

  1999cites this paper
• Gelatinase B (MMP‐9), but not its inhibitor (TIMP‐1), dictates the growth rate of experimental thymic lymphoma

  1999cites this paper
• Dissemination of T cell lymphoma to target organs: a post-homing event implicating ICAM-1 and matrix metalloproteinases.

  1999cites this paper
• INHIBITION OF MATRIX METALLOPROTEINASES THERAPEUTIC APPLICATIONS

  1999cites this paper
• Increased TIMP‐1 activity results in increased expression of gelatinases and altered cell motility

  1999cites this paper
• Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas

  1999cites this paper
• Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.

  1999cites this paper
• Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.

  1999cites this paper
• Proteolytic activity of human non-Hodgkin's lymphomas.

  1998cites this paper
• Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1.

  1998cites this paper
• Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion

  1998cites this paper
• ICAM-1 ImplicationLymphoma / Endothelial Cell Contact : Matrix Metalloproteinase-1 During T Metalloproteinase-9 and Tissue Inhibitor of Bi-Directional Induction of Matrix

  1998cites this paper
• Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice.

  1997cites this paper
• Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line

  1997cites this paper
• Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.

  1997cites this paper
• Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.

  1997cites this paper
• TIMP expression in toxic and cholestatic liver injury in rat.

  1997cites this paper
• Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9.

  1997cites this paper
• Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts

  1996cites this paper
• The biochemistry of metastasis.

  1996cites this paper
• The role of metalloproteinases and their inhibitors in hematological disorders.

  1996cites this paper
• Local activity of matrix metalloproteinases in a case of botryoid sarcoma.

  1996cites this paper
• Towards new prognostic factors in diffuse large cell non-Hodgkin's lymphoma.

  1996cites this paper
• Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.

  1996cites this paper
• Tissue inhibitor of metalloproteinases‐2 (TIMP‐2) in rat liver cells is increased by lipopolysaccharide and prostaglandin E2

  1995cites this paper
• Suppression of type IV collagenase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo.

  1995cites this paper
• Matrix Metalloproteinases and Their Inhibitors in Tumor Progression a

  1994cites this paper
• Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.

  1994cites this paper
• Matrix metalloproteinases and their inhibitors in tumor progression.

  1994cites this paper
• Regulation of tissue inhibitor of metalloproteinases‐1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures

  1993cites this paper
• Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.

  1993cites this paper
• Expression Pattern of Metalloproteinases and Their Inhibitors Changes with the Progression of Human Sporadic Colorectal Neoplasia

  1993cites this paper